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ABSTRACT  
 
Brendan Noggle 
ADOLESCENT KNOWLEDGE, ATTITUDES, AND BELIEFS TOWARD 
VACCINATION 
(Under the direction of Karen Gieseker)  
 
 
Vaccination, one of public health’s greatest disease prevention tools, is broadening to 
focus on adolescents.  Now that there are more vaccines targeted specifically for adolescents, 
it is time to give more focus to vaccine delivery in this population.  This research will 
increase the knowledge base to support informed changes in adolescent vaccine delivery by 
identifying knowledge and attitudes of adolescents toward vaccination within the context of 
barriers and solutions.  Perceived susceptibility to disease, benefits and barriers to 
vaccination and other constructs were collected through a survey to 1368 high school 
students.  In this population, a scheduled adolescent healthcare visit is feasible, vaccine 
education can diminishes health misconceptions, and vaccination mandates are ways to reach 
some students.   
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Chapter I-Introduction 
Vaccines are cited as one of the top ten greatest disease prevention tools of recent 
history [1].  The increase in vaccines recommended specifically for adolescents is a relatively 
new development; therefore the process of vaccine delivery specifically for adolescents 
needs to develop as well.  Now that there are more vaccines targeted specifically for 
adolescents, focusing on vaccine delivery to this population will help to improve chances of 
successful prevention of disease and to meet the goals of improving vaccination rates, erasing 
disparities, and preventing disease [2]. 
Vaccinating adolescents, that is, individuals from age 13 to 18, before they enter 
adulthood is vital because as adolescents enter adulthood vaccination rates drop [3].  Timing 
is important because many of the current and future adolescent vaccines are for sexually 
transmitted infections and are only efficacious if they are administered before exposure to the 
pathogen and therefore before the beginning of sexual activity [4].  National surveys have 
shown that in general, adolescent healthcare usage patterns are somewhat conducive to 
vaccine delivery [5].  These surveys revealed that most adolescents under 18 had a usual 
source of healthcare, but Asians, Hispanics, and those near or below the poverty line had less 
access.  Of adolescents that had a source of healthcare to visit, fewer actually visited their 
healthcare provider.  Furthermore, people of non-majority ethnicities and those near or below 
the poverty line visited their healthcare provider even less [5].  This was important because if 
there were no visits to a healthcare provider there were fewer chances for immunization or 
recommendation for vaccination. 
Vaccines currently recommended for adolescents by the federal advisory panel the 
Advisory Committee on Immunization Practices (ACIP), in addition to missed routine 
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childhood immunizations, are the meningococcal, human papillomavirus (HPV), and 
acellular pertussis vaccines.  The meningococcal vaccine offers protection from four of the 
most prevalent five serogroups of the bacteria that causes bacterial meningitis [6].  This 
vaccine (or at least education about the disease) is required in Georgia for college freshman 
who will live in campus housing.  The HPV vaccine can be very effective at preventing the 
foremost cause of cervical cancer [7].  Acellular pertussis prevents whooping cough, one of 
the only diseases that are on the increase in adolescents [8, 9].  With all of these diseases the 
main strategy for prevention is vaccination [10]. 
Future vaccines for adolescents include herpes simplex virus type 2 (HSV2) and 
another for cytomegalovirus [11, 12].  HSV2 has been shown to be prevalent in the United 
States and globally and causes painful genital skin lesions [13-15].  Cytomegalovirus (CMV) 
can cause death and disability if passed from mother to baby and also was found to be highly 
prevalent in the United States [16, 17].  Due to their prevalence, vaccines make good 
prevention options for both CMV and HSV2. 
While vaccinations could be the prevention answer for all of these diseases, barriers 
exist which prevent some adolescents from receiving all recommended vaccinations.  These 
barriers include non-utilization of healthcare, cost, not knowing about the seriousness of a 
disease or vaccine recommendation, fear of adverse events, distrust of medicine, or other 
social barriers [4, 10, 18-21].  Fortunately, many solutions have been offered for these 
barriers, and the most successful interventions were multifaceted and identified areas where 
vaccination opportunities have been missed [3].  Solutions include creating and promoting a 
set of health and vaccination visits for adolescents, similar to the infant and child schedule 
[10, 18], and creating standard of care endorsements by professional organizations for 
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healthcare practitioners to increase attention of providers to recommend vaccines [19].  An 
effective way of improving vaccination rates is through school entry laws [20].  These laws 
require certain vaccinations before the child can be admitted into school and, for some, have 
been the only reason vaccination occurred [21].   
Despite a good rationale for vaccination, gaps in vaccination coverage remain among 
adolescents.  These gaps should be targeted for further study to identify ways to improve 
coverage.  This especially holds true for adolescents, as coverage rates of recommended 
vaccines decline as children enter this age group.  Vaccination of adolescents is critical 
before they progress to adults and are even more difficult to reach [3].   
Despite clear interventions targeting adolescents to increase vaccine rates, 
effectiveness of some techniques were found to be minimal, only partially understood, or 
effective only for certain groups [20, 25-27].  Douglas County, Georgia high school students 
were invited to fill out a survey to increase understanding of characteristics that may be 
associated with vaccination rates and explore factors contributing to acceptance of vaccines 
and their knowledge, attitudes, and beliefs toward vaccination.  By identifying 
characteristics, attitudes, and motivation of high school students toward vaccination, this 
research aimed to identify areas of improvement to adolescent vaccine campaigns.  In 
addition, this research will study a population of students that could have received an 
educational presentation on meningococcal disease, the main cause of bacterial meningitis, 
and had an opportunity to be a part of a study to determine the serogroup specific 
effectiveness of the tetravalent meningococcal conjugate vaccine (MCV4).  Study 
participation and survey responses will be compared between student groups, such as 
demographic characteristics.  Specifically, motivations and attitudes toward vaccination 
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against bacterial meningitis was a good case study for vaccine preventable disease as a whole 
because the meningococcal vaccine is recommended by ACIP [22], prevents a rare but severe 
disease in adolescents [23], and vaccination coverage rates are under review [24].   
Socio-demographic population characteristics and beliefs were explored among 
students to determine if differences exist between schools or student groups using the 
framework of the Health Belief Model.  The purpose of this research was to use applicable 
constructs of the Health Belief Model to identify perceptions and beliefs of adolescents 
toward vaccination that could be modified or addressed to improve vaccine coverage.  
Similarities and differences in the beliefs among socio-demographic groups were 
investigated so that intervention strategies could be focused to benefit those with greater 
barriers to vaccination.  Research results were used to produce recommendations to direct 
adolescent vaccination campaigns.     
Research Questions 
The following research questions and hypotheses were tested during this study. 
1. How do students who have been to a health provider within the past year differ from 
those who have not with respect to demographic characteristics and beliefs /attitudes 
about vaccination?  
Hypothesis A: A higher percentage of students who pay full price for lunch 
compared to those who get  free or reduced lunch will at least one visit to a 
healthcare provider in the past two years.  
Hypothesis B: A higher percentage of female students compared to male students 
will have at least one visit to a healthcare provider in the past two years. 
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2. Are student demographic characteristics and beliefs about vaccination associated with 
perceived risk?  Will different groups have varying perceptions of disease risk? 
Hypothesis A: College preparatory track students will perceive a higher risk for 
meningococcal disease than technical/career track students. 
Hypothesis B: Females will perceive a higher risk for meningococcal disease than 
males. 
3. Is knowledge of vaccine recommendations associated with student exposure to 
various information avenues (operationalized as education assembly, college track, 
and healthcare provider)? Are student demographic characteristics and beliefs about 
vaccination associated with knowledge of college vaccine requirements? 
Hypothesis A: Recent healthcare users will know more about college vaccine 
requirements than other groups.   
Hypothesis B: College preparatory track students will know more about college 
vaccine requirements than other groups. 
Hypothesis C: Students who saw the educational assembly will know more about 
college vaccine requirements than those who did not. 
4. Are health care provider beliefs about vaccination related to student and parent beliefs 
about vaccination?   
Hypothesis A: The belief that the healthcare provider advocates vaccination will 
be correlated with adolescent’s individual belief that they should be vaccinated. 
Hypothesis B: Females will believe that their doctor advocates vaccination more 
than males. 
 
6 
5. Are student demographic characteristics associated with perceived decision making 
autonomy?  Do students perceive that their parents let them make vaccine decisions?  
If so, who is more likely to believe this? 
Hypothesis: Older students will feel they have more vaccine decision making 
authority than younger students. 
6. Are student demographic characteristics associated with worry about vaccine side 
effects?  Do some groups fear a vaccine side effect?  
Hypothesis A: White students fear a serious side effect less than other students. 
Hypothesis B: Students who pay full price for lunch will fear a serious side effect 
less than other students. 
7.   Are student demographic characteristics associated with parent belief that vaccines 
are dangerous?  Do some groups feel a mistrust of medicine (as operationalized by 
parent belief that vaccines are dangerous?) 
Hypothesis: White students perceive that vaccines are less dangerous than other 
populations 
8.   Does attendance at a presentation about vaccination have an effect on beliefs about 
the meningococcal vaccine and vaccines in general?  Does remembering a 
presentation and video on meningococcal disease have an effect on knowledge and 
beliefs?  
Hypothesis A: Students who remember the presentation will agree that 
meningococcal disease is a serious illness more than those who did not see the 
presentation. 
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Hypothesis B: Students who remember the presentation will agree that teens and 
young adults are at risk to catch disease more than those who did not see the 
presentation. 
Hypothesis C: Students who remember the presentation will agree that the 
meningococcal vaccine is effective more than those who did not see the 
presentation. 
Hypothesis D: Students who remember the presentation will agree that getting a 
vaccination helps others as well more than those who did not see the presentation. 
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Chapter II-Review of Literature 
Procedures for vaccinating the young and the old have been developed from the 
beginning of vaccination history because vaccines have been focused and targeted for these 
age groups.  However, this is not the case for adolescents, where, until recently, the lack of 
new vaccines to administer to this age group has not necessitated a maturing of the 
vaccination delivery process.  The number of vaccines available to adolescents is increasing 
and has the potential to double in the near future.   
Adolescence is a critical time in terms of healthcare contact.  Two major United 
States organizations, the National Immunization Program (NIP) and the Society of 
Adolescent Medicine (SAM), identified adolescents as a population that should be the focus 
of disease prevention through vaccination [3, 10].  NIP recognized that adolescents, as a 
population group, fell short of their immunization goals and programs and processes should 
evolve to meet this need.  Reaching adolescents before the end of high school is important 
because filling vaccination delinquencies in young adults is more difficult [3].  Rand 
described that adolescents aged 11 to 14 visited preventive care facilities three times more 
often than individuals aged 18 to 21 (p-value <0.001) [25].  The immunization policy of the 
American Academy of Pediatrics (AAP) recognized special care should be given to the poor, 
members or racial or ethnic communities, and those who live in inner city or rural location, 
as these groups tend to have lower vaccination coverage [26].  Additionally, SAM 
recognized that among adolescents, healthcare visits are highest in younger individuals and 
lowest in older individuals.  This is important because without a healthcare visit, vaccinations 
are unlikely to occur.  Importantly, if adolescents are seen by a health provider before the 
teen years are over they may be eligible for government assistance with the cost of vaccine.  
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SAM advocates a comprehensive preventive health strategy, utilizing all available methods 
including vaccination and effective health education [10].   
Multifaceted interventions have been successful, especially when modeled after 
public health theory.  In this case, adolescent health behavior was framed within the Health 
Belief Model.  The Health Belief Model presumes that an individual’s health related behavior 
is an interaction of perceived susceptibility and severity of disease, barriers, prevention 
benefits, self-efficacy, and cues to action [27].  By investigating the problem of low 
adolescent vaccination coverage rates using a structured approach such as the Health Belief 
Model, it is more likely that the desired outcome of improved adolescent health will be 
achieved. 
Adolescent Healthcare Use - Precursor to Vaccination 
Recent national surveys have described healthcare utilization and vaccination rates in 
children [5].  The National Center for Health Statistics, a part of the Centers of Disease 
Control and Prevention (CDC), compiled many of these population-based surveys and gave a 
more complete picture of vaccination correlates in the United States.  Their summaries, of the 
past decade, identified trends for healthcare utilization for persons with no usual source of 
healthcare and no healthcare visits, both of which could be considered vaccination barriers 
with the Health Belief Model.   
According to the summaries for the years 2001- 2004, less than 7% of children aged 
6-17 years had no usual source of healthcare [5].  In addition, these summaries identified 
specific pediatric population groups with varying degrees of the barrier to vaccination: 
lacking a source of healthcare.  Disparities between race categories were generally low and 
amounted to only a few percentage points, except for Asians who had less access.  See Table 
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1.  However, when ethnicities were compared, about 4% of non-Hispanics had no usual 
source of healthcare while Hispanics followed about 10 percentage points behind.  
Differences were greater when using percent of poverty level income as a classification 
rather than ethnicity.  Of those who had incomes at 200% of poverty level or above, 4% had 
no usual source of healthcare.  Of those below poverty level, 13 to 14% had no usual source 
of healthcare [5].  These statistics are interesting because most families, regardless of 
ethnicity, with incomes less than 200% of poverty level can receive low cost medical care 
through Medicaid or the State Children’s Health Insurance Program (SCHIP).  Therefore 
other barriers beyond income level must have affected sources of healthcare in these groups.  
 
Table 1. Percent of children without a usual source of healthcare by demographic group 
and health insurance status. 
Group Characteristic 2001- 2002 
2003- 
2004 
All 6.8% 6.4% 
White 5.8% 6.1% 
Black 8.0% 7.2% Race 
Asian 13.2% 9.3% 
Hispanic 16.0% 13.7% Ethnicity Non-Hispanic 3.7% 3.9% 
Below 100% of poverty level 13.7% 13.1% Income 200% of poverty level or above 3.8% 3.5% 
Health Insurance None within the last 12 months 38.1% 38.8% 
Adapted from: Centers for Disease Control and Prevention. Health, United States, 2006. 
Table 76. [5] 
In addition to having a source of healthcare, actual visits were also studied.  See 
Table 2.  Not visiting a healthcare provider poses another barrier to vaccination, as most 
vaccination takes place at a healthcare facility.  According to the CDC summary from 2001 
to 2004, almost 15% of all children had no visit to a healthcare practitioner that year.  By 
race, 14% of Whites, 17% of Blacks or African Americans, and 21% of Asians, Native 
Hawaiians, or Pacific Islanders had no visit to a healthcare practitioner that year.  Differences 
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in healthcare visitation were greater when using percent of poverty level as a classification.  
About three out of four people who had income at poverty level or lower visited healthcare 
within the last year, while about seven out of eight people with incomes 200% above poverty 
level had a healthcare visit.   
 
Table 2. Percent of children without a visit to healthcare by demographic group 
and health insurance status. 
Group Characteristic 2001- 2002 
2003- 
2004 
All 14.9% 14.8% 
White 13.9% 14.4% 
Black 16.8% 14.8% Race 
Asian 20.5% 22.2% 
Hispanic 24.0% 24.1% Ethnicity Non-Hispanic 13.0% 12.7% 
Below 100% of poverty level 21.8% 20.8% Income 200% of poverty level or above 11.7% 11.5% 
Health Insurance None within the last 12 months 45.3% 46.0% 
Adapted from: Centers for Disease Control and Prevention. Health, United States, 
2006. Table 79. [5] 
According to CDC data, health insurance status for adolescents was a powerful 
correlate with healthcare visits within the last year.  Almost half of those who did not have 
health insurance during the previous year did not have a healthcare visit [5].  With the 
exception of the uninsured, most children had a healthcare visit within the last year.  This 
time spent with the doctor or nurse during one of these visits could be used as a cue to action 
by recommending vaccination.  In addition, discussion between the healthcare provider and 
the adolescent can be used to increase patient knowledge of susceptibility and severity of  
vaccine preventable diseases.    
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Vaccination Goals and Strategies 
The scientific and public health communities have evaluated information from 
vaccination surveys and have set benchmarks to measure improvement and goals 
achievement.  The Healthy People 2010 initiative is a set of goals that are national in scope 
and set a strategy for “promoting health and preventing illness, disability, and premature 
death” for all people in the United States [2].  Adolescent vaccine-related 2010 goals include 
increasing routine vaccination coverage levels of hepatitis B, measles-mumps-rubella 
(MMR), tetanus-diphtheria-pertussis booster (Tdap), and varicella to 90 percent.  At the 
halfway mark, in 2005, the United States was progressing towards the goal of achieving 90% 
coverage for hepatitis B and varicella, and had already met the 90% target for MMR and 
Tdap (Table 3) [28].  Similarly, the goal of NIP is to “increase to 90% routine vaccination 
coverage levels for adolescents in the United States for each vaccine and [erase disparity by] 
achieving and sustaining 90% coverage for each racial, ethnic, and socioeconomic group in 
the United States for all vaccines.”  While these goals are lofty, NIP feels they are achievable 
and can be reached with a mix of traditional and innovative strategies [3].  
 
 
 
 
 
 
 
 
Table 3. Healthy people 2010 goals, progress, and targets. 
Objective Increase in Vaccination Coverage Levels for Adolescents Aged 13 to 15 Years 
1997 
baseline 
2005 Midcourse 
status 
2010 
Target 
14-24b. Adolescents aged 13 to 15 years who receive the recommended vaccines 
no data were available to assess 
progress 
14-27a. 3 or more doses of hepatitis B 48% Achieved 79% of target 90% 
14-27b. 2 or more doses of measles, mumps, rubella 89% Met target 90% 
14-27c. 1 or more doses of tetanus-diphtheria booster 93% Met target 90% 
14-27d. 1 or more doses of varicella (excluding children who have had varicella) 45% 
Achieved 71% 
of target 90% 
Adapted from: U.S. Department of Health and Human Services, Healthy People 2010 Midcourse 
Review: Immunization and Infectious Diseases. [28] 
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Another strategy used to vaccinate children and adolescents is a school entry law, 
which requires certain vaccinations before the child can be admitted into school.  When 
placed in the framework of the Health Belief Model, school entry laws create a perceived 
benefit of vaccination, in that when vaccination requirements are met, adolescents can attend 
school.  The state of Massachusetts passed the first law in 1855 that required smallpox 
immunization before entry into school.  Now, all 50 states have followed Massachusetts’ lead 
and instituted state school entry laws [29].  In Georgia, high school students must have Tdap, 
hepatitis B, polio, MMR, and varicella vaccinations, or a religious exemption before entrance 
into school [31].  Students attending any college or university in Georgia are required to have 
a meningococcal conjugate vaccine, or at least information about meningococcal disease and 
the vaccination, in addition to the vaccines required in high school [32, 33].  Private colleges 
and universities must enforce the meningococcal requirements and can enforce other 
immunization requirements as well if seen fit [31].  Today, as a result of school entry laws, 
high school age adolescents receive vaccines, such as MMR, Tdap, Haemophilus influenza 
type b (Hib), or hepatitis B, not because they were recommended specifically for their age 
group, but because they were missed earlier in life.  In general, adolescent vaccines are so 
new that school entry laws have yet to be written and continue to be debated as science 
continues to determine the vaccine’s effectiveness and safety.  The American Academy of 
Family Physicians (AAFP) will recommend a HPV immunization mandate before school 
admission only after “long term safety with widespread use, stability of supply, and 
economic issues have been clarified [34].”  
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Current Vaccines for Adolescents 
Currently, three vaccines are recommended by ACIP specifically for high school 
adolescents.  ACIP is a federal advisory committee with members from federal organizations, 
such as the Department of Defense, Food and Drug Administration (FDA), and National 
Institutes of Health, and professional organizations such as the AAFP, AAP, American 
College of Obstetricians and Gynecologists, and the American Medical Association (AMA), 
among others.  ACIP is the only federal organization to make vaccine recommendations in 
collaboration with numerous external organizations; these recommendations represent broad 
interests and are considered good standard of care [35].   
One of the first vaccines recommended for adolescents was a polysaccharide vaccine 
to protect against four serogroups of Neisseria meningitidis.  An updated version of this 
vaccine, MCV4, protects against four of the most prevalent five serogroups of N. 
meningitidis, A, C, Y, and W-135.  In the United States, N. meningitidis is the leading cause 
of bacterial meningitis. Although it is a rare disease with an incidence rate of 0.5 to 1.1 cases 
per 100,000 people; the case fatality rate was 10 to 14%.  Of those that survived invasive 
meningococcal disease, 11 to 19% had lasting side effects such as neurologic or physical 
disability [22].  Due to the high morbidity and mortality associated with bacterial meningitis, 
MCV4 is recommended by ACIP for previously unvaccinated adolescents over 11 and 
students who will attend colleges or universities [6].  FDA has recently licensed MCV4 for 
children as young as 2 years of age, although ACIP has not yet discussed recommendations 
for children under 11 [36]. 
The vaccination for HPV, the foremost cause of cervical cancer [37], has been a part 
of the adolescent immunization schedule since 2006 [6], and is recommended by ACIP for 
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women from 9 through 26 years of age [35].  An estimate by Weinstock in 2004 revealed that 
HPV had the highest incidence of all sexually transmitted diseases in the United States [13, 
38-40].  HPV infections can cause genital warts, cervical, or anal cancer [39].  Merck & Co, 
Inc., the maker of the only HPV vaccination currently licensed and recommended by ACIP, 
announced that multi-year clinical trials showed 100 percent efficacy in prevention of 
serogroup specific (6, 11, 16, 18) HPV disease among subjects that received the vaccine 
exactly as prescribed and who were HPV disease free at the time of vaccination [7].  The 
HPV vaccine does not, however, offer much protection against cervical cancer in persons 
who received the vaccine after they were infected with vaccine serogroups of HPV [7].  
Despite the efforts of many in public health education, the fact that HPV is a sexually 
transmitted infection has prevented many parents from accepting the vaccine and consenting 
to vaccination of their adolescent [19, 41].   
Less controversial is the acellular vaccine for prevention of pertussis, more 
commonly known as whooping cough.  This vaccine is given along with a tetanus and 
diphtheria booster and is recommended for individuals from 10 to 65 years of age [35].  In 
the United States, from 2001 to 2003, incidence of pertussis increased substantially in the 
adolescent age group from 5.5 cases to 10.9 cases per 100,000 persons [8, 42].  Waning 
immunity from the pertussis vaccination given in childhood has been shown to leave 
individuals less protected from and more likely to catch and spread pertussis [43].  Early 
pertussis symptoms are similar to a cold but can progress into severe cough, fatigue, and 
more serious symptoms which can last over a month.  Treatment after the first few weeks of 
disease does little to reduce symptoms so the main strategy for containment is prevention 
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through vaccination [10].   Most importantly, some researchers believe that pertussis could 
be eliminated through a rigorous adolescent and adult booster vaccination program [43]. 
Future Vaccines for Adolescents 
Two new vaccines, one for HSV2 and another for cytomegalovirus, soon may be 
available if the FDA finds them safe and effective [11, 12].  The vaccine is currently being 
tested in a phase III trial to determine its effectiveness.  HSV2 can cause painful genital skin 
lesions and infection is widespread in the United States and globally [13-15].  As with the 
HPV vaccine, the HSV2 vaccine faces the same sexually-transmitted-infection-vaccine 
stigma challenges; potential acceptance is currently under study [44, 45].   
The CMV vaccine is currently in phase II trials.  CMV is a human herpesvirus that is 
usually harmless to adults but can lead to death, or disability such as vision or hearing loss 
and mental retardation when passed from mother to baby.  Overall yearly prevalence of 
congenital CMV is 640 cases per 100,000 persons (0.64%) in the United States (40,000 
children in the United States) and the rest of the world making a vaccine a strong prevention 
option [16, 17].  See Table 4 for a summary of current and future vaccine for adolescents. 
Barriers to Vaccination  
As introduced through discussion of healthcare utilization, barriers to adolescent 
vaccination exist.  Additional reasons for non-vaccination can include an unawareness of the 
vaccine, its necessity and recommendations, or personal and cultural beliefs against 
vaccination [38, 46-49].  Adolescents’ vaccination behavior is dependant on many individual 
internal and external factors in addition to those of their parents.  Vaccine barriers addressed 
in this study were framed within the constructs of the Health Belief Model and included non-
utilization of healthcare, cost, education of disease risk and recommendations, fear of a side 
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Table 4.  Current and future vaccines for adolescents, disease agent, symptoms, doses needed 
for full regimen, and private sector cost per dose. 
 Vaccine Abbr. For Prevention of… 
Disease 
Symptoms 
# 
Doses
$ / 
Dose
Tetravalent 
Meningococcal 
Conjugate 
MCV4
Neisseria 
meningitidis 
serogroup A,C, 
Y, W135 
Meningitis, 
sepsis, 
pneumonia 
1 $89 
Quadrivalent 
Human 
papillomavirus 
HPV 
Human 
papillomavirus 
serogroup 6, 11, 
16, 18 
Cervical 
dysplasia, 
genital 
warts 
3 $120
Current 
Vaccines 
Recommended 
by ACIP for 
Adolescents 
Pertussis (with a 
tetanus and 
diphtheria 
booster) 
Tdap Bordetella pertussis 
From cold-
like to 
persistent 
whooping 
cough 
1 $37 
Herpes Simplex 
virus type 2 HSV2 
Herpes Simplex 
virus type 2 
Genital 
skin lesions -- -- 
Potential 
Future 
Vaccines 
Cytomegalovirus CMV Cytomegalovirus 
Mild to 
disability 
and death 
in 
newborns 
-- -- 
 
effect, social barriers, and mistrust of medicine.  Individual barriers, as well as the 
cumulative effect of multiple barriers, have the potential to negatively affect self-efficacy, the 
feeling that the individual has the ability to make a behavioral change that leads to a positive 
health outcome. 
Non-utilization of Healthcare 
One formidable barrier to adolescent immunization is non-utilization of preventive      
(or any) healthcare [10].  Within the framework of the Health Belief Model, if vaccine 
education occurs during healthcare visits, there is the opportunity to affect perceived 
susceptibility and severity of disease, and perceived benefits of vaccination.  The AMA 
recommends three visits during adolescence; one early visit for ages 11-14, one middle visit 
for ages 15-17, and one late visit for ages 18-21 [46].  It is under debate as to what visit 
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adolescent vaccinations should be administered.  Current recommendations match potential 
healthcare visits to utilization patterns accounting for the number of vaccine doses needed to 
create immunity and reduce carriage.  In general, it is thought that vaccines should be 
administered at the earliest healthcare visit possible to maximize the chance that the 
adolescent will complete the vaccine series [25].  Early vaccination is better because it also 
reduces the time period that adolescents could be in contact with infectious diseases through 
sexual activity or close personal contact.   
Utilization often is unequal across races, ethnicity, insurance status, and family 
income with highest contact among non-Hispanic Whites, those with health insurance and 
higher income [47].  Within the framework of the Health Belief Model, lack of healthcare 
utilization reduces potential cues to action, or recommendations about vaccination by a 
healthcare practitioner.  Also, adolescents over 15 years of age were less likely than younger 
ones to have health insurance, and thus were less likely to receive healthcare [47].  Overall 
outpatient visits to any healthcare provider decreased in males after age 11 but increased in 
females.  After this age, preventive healthcare visits (well-child visits) to pediatricians or 
family practice physicians declined sharply for males and slightly less sharply for females 
[25].  The increases in outpatient visits and less sharp decrease in well-child visits in females 
were due to an increase in visits to obstetrician/gynecologist physicians during this age.  
Reasons why adolescents do not visit a healthcare practitioner may include a lack of health 
insurance, no geographic access, perceived good health, rejection of the type of care offered, 
or cost [25]. 
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Cost 
Many vaccines are expensive, some over one hundred dollars a dose [48].  When 
multiple doses of these vaccines are needed, such as with the three dose series HPV vaccine, 
cost can become a major barrier.  Within the Health Belief Model, perception of inability to 
pay for vaccines will reduce the likelihood that vaccination will occur.  The entire cost of 
childhood immunization could be over $700 [49].  Cost as a barrier also extends beyond the 
retail price of vaccine.  The cost of missed working hours for the parent, or transportations 
costs to and from the doctor also must be considered.  This problem is compounded by the 
fact that many adolescents do not have private health insurance, or alternatively, do not take 
advantage of public programs such as Medicaid, SCHIP, or the Vaccines for Children (VFC) 
program.  Medicaid and SCHIP are federally mandated programs but allow individual states 
to set their own guidelines and eligibility criteria while meeting certain minimum 
requirements.   
To reduce cost as a barrier, state Medicaid programs attempt to offset the cost of 
health services by offering healthcare and vaccination services to children under 6 years of 
age whose family is living at or below 133% of the poverty level, and to children from 6 to 
19 years of age who are at 100% of poverty level, including children in other categories such 
as the medically needy [50].  Even though the cost of insurance is covered through one of the 
aforementioned programs, persons with income <100% of poverty level are least likely to use 
preventive care, so other components of cost (lost wages, transportation) may need to be 
considered [51].  SCHIP offers services to children up to age 19 with a family income above 
that which would include them in Medicaid but below an income that would allow them to 
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afford private medical insurance.  SCHIP benefits include healthcare and vaccinations for 
enrolled children [50].   
In addition to government programs that attempt to provide general healthcare for low 
income or medically needy populations, the VFC program attempts to lessen the cost barrier 
for vaccines specifically.  VFC provides free vaccines to public and private providers by 
purchasing large amounts of vaccine, giving that vaccine to providers at no cost who in turn 
administer them to qualifying children less than 19 years of age for free or at low cost [52].  
In Georgia, VFC eligibility includes children that are uninsured, underinsured (i.e. 
vaccinations are not covered by private insurance), American Indian or Alaska Native, or 
Medicaid-eligible.  In Georgia, costs to the patient may not exceed $14.81 per injection plus 
an optional office visit fee that can vary by provider [53].  The idea behind VFC is to prevent 
private providers from sending un- or underinsured children to other facilities to receive free 
vaccine by shifting the cost from private providers to the government so that the patient can 
be seen by their provider of choice.  Interestingly, children who are eligible for the VFC can 
often receive vaccines more easily than children with private insurance.  This is because 
healthcare offices that participate in the VFC program get VFC vaccines for free for VFC 
qualifying children; for non-VFC children, healthcare providers have to buy them up front 
and wait for reimbursement from their patient’s private insurer.  This up front cost and 
associated financial risk is often large and limits availability of vaccines for non-VFC 
children [54].   
These federally funded and mandated programs provide a framework that provides 
necessary healthcare services to those who might not otherwise be able to afford them, 
helping to remove cost as a barrier to vaccination.  However, their federal funding can be 
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their fundamental flaw.  If for some reason the executive or legislative branches of 
government do not come to an agreement on funding or management of the programs, the 
healthcare benefits for the children and adolescents they are designed to serve may cease 
rendering these children without healthcare [49]. 
Lack of Education 
Lack of education of the need for vaccinations represents another barrier to 
vaccination.  Keeping within the framework of the Health Belief Model, vaccine education 
can contribute to an individual’s perceived severity and susceptibility which could lead to 
vaccination.  A survey of physicians noted that about half to two-thirds of adolescents were 
not aware of the need for vaccinations.  Also, half of physicians responded that the 
adolescent’s underestimation of the risks of vaccine preventable disease is the primary barrier 
of vaccination [55].  General education level of the parents of adolescents played a role in 
whether or not their adolescent gets vaccinated.  If an adolescent’s parent was without a high 
school degree, the child was half as likely as other adolescents to utilize healthcare and thus 
have an opportunity for vaccination [51].  Herd immunity is the ability of a vaccine to protect 
close contacts, such as friends and relatives, because of the reduced risk of transmission of 
the disease from the vaccinated person and is an added perceived benefit of vaccination.  
Without this knowledge, one might not feel vaccinations are as important.   
Often the timing of vaccination is important.  Adolescents and adults need to be made 
aware that the HPV vaccine is most effective before exposure to HPV, which often comes 
shortly after the onset of sexual activity [45].  Physicians, parents, and adolescents must learn 
about what vaccinations are needed at what specific time or age for the greatest chances of 
vaccination and disease prevention [4].   
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A perceived barrier to vaccination was the risk of adverse events that was often 
associated with vaccinations [4].  Recently, questions had arisen concerning the safety of 
vaccines.  An internet search on “vaccination” yielded results from CDC and NIP as well as 
anti-vaccine groups that propagated misconceptions and misinformation about vaccines.  
Parents have reported feelings that children received more vaccines than were good for them, 
or that vaccines weaken the immune system [56].  Common vaccine side effects were 
redness, swelling, or soreness at the injection site.  More serious reactions do occur but were 
rare, such as the increased risk of Guillain-Barré syndrome amongst MCV4 recipients [57].  
Knowledge of the real risk a vaccine poses to the adolescent is often not relayed by a 
reputable source.  Parents and adolescents must be educated that for ACIP to recommend a 
vaccine, the risk of acquiring the disease must greatly outweigh the risk of a vaccine related 
adverse event. 
Vaccine acceptance can be hindered by social barriers.  One issue that arises during 
adolescents is sexual intercourse.  HPV, HSV2, and to a small extent, CMV are spread 
sexually.  Parents often take strong and diverse stances on the issue.  The views of parents fit 
within the framework of the Health Belief Model in that rejection of vaccine creates barriers 
while perceived benefits of vaccination make vaccination more likely in their adolescent.  
Due to the association of HPV as a sexually transmitted infection, parents may have felt that 
accepting the vaccine is tantamount to accepting or promoting risky sexual behaviors [38].  
While some parents accepted these vaccines as a result of a desire to protect children, other 
parents had the perception that their child was not susceptible to acquiring these diseases.  
However, the desire to protect usually took precedence [45].  One study showed that written 
parent educational materials on the risks of HPV improved knowledge of the disease but 
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were not enough to convince the parent to accept child vaccination [58].  This finding was 
opposed in another study [59], implying that reason does not always affect health decisions.  
Parental consent is required for most vaccinations, thus parental attitude toward vaccines is a 
strong determinant of child vaccination.  Additionally, parental attitude toward vaccination 
was a strong predictor of adolescent attitudes [45]. 
Additional social barriers included a distrust of medicine or medical technology [60] 
and these concerns seemed to vary between racial and ethnic groups.  Within the Health 
Belief Model, this distrust is a barrier to vaccination.  Focus groups with African American 
participants have uncovered concerns such as ingredients of the vaccination, un-consented 
experimentation, rushed medical visits coupled with a long wait at healthcare facilities, poor 
treatment in general, and a healthcare provider who was not easy to talk to [21, 60, 61].  
Hispanic parents were concerned about vaccine ingredients more than White parents.  
African Americans were more likely than Whites to cite vaccination as a high level concern 
and did not think their health care provider always acted in the adolescent’s best interest [21, 
56].  The communication with the healthcare practitioner necessary to help solve these issues 
can be absent or difficult for the uneducated as well as the poor, who may have less 
continuity with providers [21].   
In addition to vaccine acceptability, feelings of invincibility may influence vaccine 
coverage rates.  Adolescents may have low perceived susceptibility towards disease, and 
many think that people in general might acquire a disease but just not them.  Feelings of 
invulnerability also can extend to contained communities, religious or otherwise.  These 
communities with little contact with the outside world may or may not advocate vaccination 
to their residents because they do not feel like disease is a risk to them.  These feelings 
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remain despite periodic outbreaks of vaccine preventable disease inside and outside of these 
communities [9, 61, 62].  Moreover, laws exist that allow people to avoid legally mandated 
vaccinations on religious or moral grounds. 
Of those that have nothing against vaccinations but just don’t know about vaccines or 
recommendations, one of the most cited reasons for not knowing about a recommended 
vaccination was lack of physician advisement on the issue [55].   There were many additional 
vaccine delivery factors that determined adolescent immunization.  One of the first was 
optimizing the immunization schedule to advise when adolescents should be vaccinated.  
This decision took into account assuring vaccination before exposure and adolescent 
healthcare visit feasibility considering cost and needed immune response [3].   
 Many of these barriers have simple solutions, while others are complex.  Some 
straightforward barriers can be remedied through education.  Many of the other complex 
barriers to vaccination are the same as those that are at the root of social disparities.  As 
framed in the Health Belief Model, one should not view barriers as independent, but instead 
as components that converge to yield the final decision to vaccinate or not.  As measured by 
progress toward meeting the Healthy People 2010 goals, improvement is occurring.  To 
ensure that vaccine coverage disparities do not exist and universal coverage is achieved, the 
solutions to these barriers put forth by experts must be put into action and tailored to meet the 
lifestyle of adolescents, where possible.  Understanding the vaccination knowledge, attitudes, 
and beliefs of the adolescent population is critical to overcoming these barriers and improve 
vaccination process.  Focusing on issues that impact adolescent’s perceived susceptibility and 
severity of vaccine preventable disease as well as adolescent’s perceived benefits and barriers 
to vaccines are critically important as the list of vaccines for this age group expands. 
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 Chapter III-Methods and Procedures 
  
Study Population 
The study population included adolescents that were students in grades 9 through 12 
during the first week of May, 2007 from the four Douglas County, Georgia public high 
schools.  Douglas County had an estimated overall population of 119,557 persons in 2006 
and is a part of the Atlanta Metropolitan Statistical Area.  In 2005, 60.8% of the Douglas 
County population were White non-Hispanic, 31.6% were Black, 4.9% were Hispanic, and 
1.3% were Asian.  The last recorded median household income was $49,964 in 2005.  These 
population statistics closely approximated those of Georgia as a whole [62]. Three of the 
schools, Alexander, Douglas County, and Lithia Springs, were within two miles of the I-20 
corridor, while the fourth school, Chapel Hill was within four miles.  See Figure 1 for a map 
of Douglas County, Georgia. 
Figure 1.  Map of Douglas County, GA. B-Douglas County HS, C-Alexander HS, E-Chapel 
Hill HS, G-Lithia Springs HS.  ©2007 Google Map. 
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The Douglas County School system student population was unique from other metro 
Atlanta school systems because they had an opportunity to participate in a study concerning 
the serogroup specific effectiveness of MCV4, the tetravalent meningococcal conjugate 
vaccine produced by Sanofi Pasteur (hereafter the MCV study).  The study’s purpose was to 
compare differences in serogroup-specific carriage of N. meningitidis between control and 
intervention schools (initially vaccinated and unvaccinated) to determine MCV4 vaccine 
effect on carriage.  This study occurred from October 2006 to March 2007 on school grounds 
and involved about 25% of Douglas County High school students.  Informational posters and 
announcements were present in each school involved.  During the recruitment phase of that 
study, students also received education on meningococcal disease through an assembly style 
presentation.  The education that most students received was framed in the Health Belief 
Model and could have affected the knowledge and beliefs studied in this research since this 
research occurred at the end of the school year. 
The MCV study was a result of a collaboration of the Division of Public Health of 
DHR, CDC, and the Douglas County, Georgia school system.  It was undertaken to evaluate 
the effect of MCV4 on serogroup-specific carriage of N. meningitidis.  After an educational 
assembly on meningococcal disease, about one quarter of the student body decided to 
participate in the MCV study, which involved three throat swabs to culture N. meningitidis, 
and MCV4 vaccination if they had not been vaccinated previously.  Students were paid $10 
for each of the three swab sessions for that study.  The study involved interaction with over 
1800 volunteer student participants from four diverse high schools in Douglas County during 
three study days, once in October 2006, once in January 2007, and once in April 2007.     
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Research Design  
 For this study, a cross section of adolescent students were surveyed during the first 
week of May 2007 during a classroom, homeroom, or advisement type session to gain an 
understanding of characteristics that may be associated with vaccination rates and explore 
factors contributing to acceptance of vaccines and the knowledge, attitudes, and beliefs 
regarding vaccination.  The survey questions fell into two main categories: questions 
concerning meningococcal disease and the meningococcal vaccine, and questions about 
vaccines in general.  The meningococcal related questions concerned disease risk, vaccine 
effectiveness, recommendations, and other questions that related to the education received 
earlier at the school during the MCV study.  The general vaccine questions asked about 
internal feelings and external influences that may affect the decision for an adolescent to 
receive a vaccine.  The survey consisted of 22 Likert-style questions, one yes/no/don’t know 
question, and one question on years since the most recent healthcare visit.  Additionally, 
basic demographic information was collected.  The survey responses and other vaccine 
information gained from the MCV study were compared to demographic indicators such as 
race/ethnicity, college track, and participation in free or reduced lunch.  The race/ethnicity 
indicator was used to determine differences in vaccination beliefs in race and ethnicity 
categories.  The college track variable was used to determine differences in students that did 
and did not plan on attending secondary education, and was used as a weak social status 
indicator.  The free or reduced lunch variable was a direct measure of economic status and 
was used to determine differences in vaccine beliefs in students from families that did and 
did not have low income.  Questions on topics that approximate the barriers and facilitators 
of vaccination were treated as dependant variables.  These included years since last 
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healthcare contact, perceived risk and severity, and adolescent decision-making capability.  
Independent variables included race, ethnicity, gender, age, participation in free or reduced 
lunch, degree program, and others.  The survey was developed by the author and reviewed by 
members of the Georgia Department of Human Resources (DHR) epidemiology branch 
notifiable disease section, with a final review by Walter Orenstein, MD.  The survey as it was 
administered to students can be viewed in Appendix A. 
Data Collection 
Data for this thesis project came from the survey just described and secondary (MCV 
study) data from the same student population with individual level student administrative 
information, such as race/ethnicity, degree track, and free or reduced lunch status.  To 
facilitate survey delivery by classroom teachers, packets for every classroom of each school 
were compiled.  These packets contained an instruction sheet for the administrators.  For 
each student, the packets contained a parent information sheet which was designed to go 
home with the student to inform the parents of the study, a student assent form, a survey, and 
a Pearson NCS answer sheet.  Every student in Alexander, Chapel Hill, and Douglas County 
high schools had an opportunity to complete a survey.  Lithia Springs High School surveyed 
only MCV study students.  Once the surveys were administered, the answer sheets were 
collected and the student assent form went home with the student.  The answer sheets were 
scanned by the Georgia State University Testing Office and converted to a text file.  These 
files were then imported into a Microsoft Access database to be merged with other data 
sources. 
With the consent of school authorities, survey responses were merged with student 
race/ethnicity, degree track, and participation in free or reduced lunch information collected 
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at the board of education, and the database was anonymised.   Student records used for 
analysis were those that matched successfully based on first name, last name, birthdate, and 
school.  To assure student confidentiality, the match occurred on the Douglas County Board 
of Education premises and student personal identifiers name and birthdate were deleted 
before leaving, but after birthdate was replaced by age at the time of the survey for all 
students. 
DHR and CDC have agreed that data from this study can be used for thesis purposes.  
This study was approved by the Georgia State University and DHR Institutional Review 
Boards numbers HO7311 and 060702, respectively.   Clearance to administer the survey 
from the Douglas County school system’s office of the superintendent followed the approval 
of a Family Educational Rights and Privacy Act (FERPA) compliant student confidentiality 
plan. 
Statistical Analysis 
Most survey answer choices used for this study were ordinal, with the exception of 
the question: “how many years has it been since you went to the healthcare provider (out side 
school) for a checkup,” which was considered interval scale.  These responses were stratified 
against demographic measures such as student age, an interval measure, and other nominal 
measures, such as sex, race/ethnicity, degree track, and lunch payment status to test for 
statistical difference.  
Chi square (χ2) analysis was used to measure the difference in the dispersion of 
responses for ordinal data such as sex or lunch payment status and nominal or ordinal data.  
The one way analysis of variance (ANOVA) was used to measure differences in ordinal 
categories against interval measures, such as age.  The Mann-Whitney U and the Wilcoxon 
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Signed Ranks are nonparametric tests that determine the magnitude of the difference between 
two populations using ranks instead of normal parameters.  The Mann-Whitney U test was 
used to determine differences in the median values of categorical survey responses, such as 
vaccine related beliefs, against a dichotomous variable, such as viewing a presentation or not.  
The Wilcoxon Signed Ranks Test was used to determine differences in survey responses 
between paired groups of questions for a related sample, such as disease risk with and 
without vaccination.  The Pearson correlation coefficient was used to determine association 
between vaccine-related beliefs, such as the correlation between parent and doctor beliefs.  
Data Management 
In the Douglas county school system administrative records, race and ethnicity were 
recorded in a single variable.  Valid values included Asian, Black, Hispanic, Multiracial, and 
White.  For this analysis, this grouping was separated.  Race categories were considered 
White and all others.  Ethnicity categories were considered Hispanic and all others.  Degree 
track programs included a college preparatory track, a technical/career oriented track, and 
both college preparatory and technical/career oriented option.  In results tables, these 
divisions were named: College Prep, Technical/Career, and Both.  Please see Appendix A. 
for all questions asked. 
Research Questions and Hypotheses 
The main goal of this research was to determine population groups that may need 
extra emphasis and attention to reach vaccination goals and identify avenues to reach them 
using applicable constructs of the Health Belief Model.  Answering the research questions 
could inform decision makers of potential solutions to improve adolescent vaccination rates. 
1. Healthcare Contact 
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 How do students who have been to a health provider within the past two years differ 
from those who have not with respect to demographic characteristics and beliefs /attitudes 
about vaccination? 
Hypothesis A: A higher percentage of students who pay full price for lunch compared to 
those who qualify for free or reduced lunch will have had at least one visit to a healthcare 
provider in the past two years.  
Hypothesis B: A higher percentage of female students compared to male students will have 
had at least one visit to a healthcare provider in the past two years. 
2. Perceived Disease Risk 
Are student demographic characteristics and beliefs about vaccination associated with 
perceived risk?  Will different groups have varying perceptions of disease risk? 
Hypothesis A: College preparatory track students will perceive a higher risk for 
meningococcal disease than technical/career track students. 
Hypothesis B: Female students will perceive a higher risk for meningococcal disease than 
male students. 
Hypothesis C: Individuals will perceive a higher risk for meningococcal disease for teens in 
general than for their own individual risk. 
3. Knowledge of Recommendations 
Is knowledge of vaccine recommendations associated with student exposure to various 
information avenues (as operationalized as education assembly, college track, and healthcare 
provider)?  Are student demographic characteristics and beliefs about vaccination associated 
with knowledge of college vaccine requirements? 
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Hypothesis A: Recent healthcare users will know more about college vaccine requirements 
than non healthcare users.   
Hypothesis B: College preparatory track students will know more about college vaccine 
requirements than students on the technical/career degree track. 
Hypothesis C: Students who saw the educational assembly will know more about college 
vaccine requirements than those who did not see the assembly. 
4. Effect of the Healthcare Practitioner, Parent, and Individual’s Beliefs 
Are health care provider beliefs about vaccination related to student and parent beliefs about 
vaccination?  Do the beliefs of others impact the beliefs of the adolescent? 
Hypothesis A: The belief that the healthcare provider advocates vaccination will be 
correlated with adolescent’s individual belief that they should be vaccinated. 
Hypothesis B: Females will believe that their doctor advocates vaccination more than males. 
5. Who Makes Vaccine Decisions? 
Are student demographic characteristics associated with perceived decision making 
autonomy?  Do students perceive that their parents let them make vaccine decisions?  If so, 
who is more likely to believe this? 
Hypothesis: Older students will feel they have more vaccine decision making authority than 
younger students. 
6. Vaccine Related Injury 
Are student demographic characteristics associated with worry about vaccine side effects?  
Do some groups fear a vaccine side effect? 
Hypothesis A: White students fear a serious side effect less than students of other races. 
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Hypothesis B: Students who pay full price for lunch will fear a serious side effect less than 
students that qualify for free or reduced lunch. 
7. Mistrust of Medicine and Providers 
Are student demographic characteristics associated with parent belief that vaccines are  
dangerous?  Do some groups feel a mistrust of medicine (as operationalized by parent belief 
that vaccines are dangerous?) 
Hypothesis: White students perceive that vaccines are less dangerous than students of other 
races. 
8. Benefit of Education via Assembly and Movie 
Does attendance at an oral and video presentation about vaccination have an effect on beliefs 
about the meningococcal vaccine and vaccines in general?  Does remembering a presentation 
and video on meningococcal disease have an effect on knowledge and beliefs? 
Hypothesis A: Students who remember the presentation will agree that meningococcal 
disease is a serious illness more than those who did not see the presentation. 
Hypothesis B: Students who remember the presentation will agree that teens and young 
adults are at risk to catch disease more than those who did not see the presentation. 
Hypothesis C: Students who remember the presentation will agree that the meningococcal 
vaccine is effective more than those who did not see the presentation. 
Hypothesis D: Students who remember the presentation will agree that getting a vaccination 
helps others as well more than those who did not see the presentation. 
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Chapter IV-Results 
At the time the survey was delivered, 7349 students attended Alexander, Chapel Hill, 
Douglas County, and Lithia Springs High Schools, according to the Douglas County Board 
of Education Administrative records.  Of these students, 1629 (22%) completed a survey. Of 
those who completed a survey, 1392 (85%) were able to be matched by name, grade, school, 
and date of birth with school administrative records.  At Lithia Springs High School, only 
students involved in the MCV study were sampled.  These students were excluded thereby 
reducing the total number of participants to 1368.  For reference, Alexander, Chapel Hill, 
Douglas County, and Lithia Springs High School students that took the survey and were also 
a part of the MCV study numbered: 215, 100, 93, and 24, respectively.  See Table 5 for a 
description of the student sample. 
 
 
 
Table 5. Description of the student sample. 
Characteristic n % 
All 1368 100.0 
Male 605 44.2 Sex Female 763 55.8 
Full pay 860 62.9 
Reduced 122 8.9 Lunch Payment Free 386 28.2 
Hispanic 67 4.9 Ethnicity Non-Hispanic 1301 95.1 
White 744 54.4 Race Other 624 45.6 
College Prep 1223 89.8 
Both 98 7.2 Degree track Technical/Career 41 3.0 
Saw 925 67.6 
Missed 245 17.9 Saw Presentation Excluded/ Don’t Know 198 14.5 
Mean (median) age 1368 16.5 (16) 
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Healthcare Contact 
Students were asked: “how many years has it been since you went to a healthcare 
provider (outside school) for a checkup?”  As noted in Table 6, four out of five (80.4%) 
students visited a healthcare provider within last two years, the same time span as the 
healthcare visit schedule recommended by AAP and SAM.  The results varied based on 
demographics and potential influences.  Within the last two years, more females than males 
visited a healthcare provider, 84.3% versus 75.5%, respectively (p-value <0.001).  More 
students who paid full price for lunch had visited a healthcare provider more frequently than 
students with reduced or free lunch, 83.1% versus 71.6% and 77.0%, respectively, (p-value 
0.003).  It was slightly more likely for White and Hispanic students to visit healthcare more 
recently, (p-values 0.02 and 0.03).   
 
Table 6.  Differences in demographic characteristics between students that had and had 
not visited a healthcare provider within the last two years.  Chi-square tests were 
performed unless otherwise specified. 
 n % <2 year 
% > 2 
year χ
2 p-value 
All 1261 80.4 19.6   
Male 556 75.5 24.5 Sex Female 705 84.3 15.7 15.0 <0.001 
Full pay 804 83.1 16.9 
Reduced 109 71.6 28.4 Lunch Payment Free 348 77.0 23.0 
11.6 0.003 
Hispanic 66 90.9 9.1 Ethnicity Non-Hispanic 1195 79.8 20.2 4.9 0.03 
White 695 82.9 17.1 Race Other 566 77.4 22.6 6.0 0.02 
College Prep 1125 80.6 19.4 
Both 97 79.4 20.6 Degree track Technical/Career 34 76.5 23.5 
0.43 0.8 
Age# 1261 16.6 16.6  0.7 
#Mean age.  T-test performed 
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Students who visited healthcare within the last two years agreed more often that 
“Regardless of what others say, I think I should be vaccinated” (p-value <0.001).  Students 
who disagreed that their parents think vaccines are dangerous visited healthcare more 
recently (p-value <0.001).  Recent healthcare users agreed more than less recent users that 
“My parents / guardians want me to receive all recommended vaccines” (p-value <0.001).  
See Table 7 for full results. 
 
Table 7.  The effect of a recent healthcare visit on vaccine-related beliefs. Mann-Whitney 
U test was used to determine differences in beliefs between students who had and had not 
visited the Healthcare provider in the last two years. 
<2 year  >2 year  
Question* 
Disease Perceived Risk 
Overall, most students strongly agreed that meningococcal disease was a serious 
illness (61.4%).  Females, more often than males, strongly agreed that meningococcal disease 
Median 
response Mean 
Median 
response Mean 
p-value
Regardless of what others say, 
I think I should be vaccinated 2-Agree 2.21 3-Uncertain 2.55 <0.001 
My doctor / healthcare 
provider thinks I should be 
vaccinated 
3-Uncertain 2.35 3-Uncertain 2.67 <0.001 
My parents / guardians think 
vaccines are dangerous 4-Disagree 3.79 3-Uncertain 3.37 <0.001 
My parents / guardians want 
me to receive all 
recommended vaccines 
2-Agree 2.12 3-Uncertain 2.38 <0.001 
My parents / guardians let me 
decide if I should be 
vaccinated 
3-Uncertain 2.96 3-Uncertain 2.96 0.9 
The meningococcal vaccine is 
recommended for students 
who plan to go to college 
2-Agree 1.98 2-Agree 2.26 <0.001 
The meningococcal vaccine is 
required for students who plan 
to go to college 
2-Agree 2.24 2-Agree 2.40 0.04 
*Valid responses: 1-Strongly Agree, 2-Agree, 3-Uncertain, 4-Disagree, 5-Strongly Disagree.
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was serious, and that teenagers, young adults and they themselves were at risk (p-value 
<0.001, for all).  Students who agreed that teenagers were at risk also tended to be younger 
than those who did not (p-value 0.03).  Technical/career degree seekers strongly agreed less 
than college preparatory degree track students about disease risk, but these values failed to 
reach significance (p-value <0.35).  See Tables 8 and 9. 
 
Table 8. Differences in demographic characteristics between students and their belief that 
meningococcal disease is a serious illness. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 61.4 24.4 12.4 1.2 0.5   
Male 53.0 27.9 16.3 1.8 1.0 Sex Female 68.1 21.8 9.4 0.7 0.1 39.1 <0.001
Full pay 61.2 25.8 11.5 0.9 0.6 
Reduced 61.5 20.5 15.6 2.5 0.0 Lunch Payment Free 62.0 22.7 13.5 1.3 0.5 
6.7 0.6 
Hispanic 53.0 31.8 15.2 0.0 0.0 Ethnicity Non-Hispanic 61.9 24.1 12.3 1.2 0.5 3.9 0.4 
White 61.7 25.8 10.6 1.4 0.5 Race Other 61.1 22.8 14.6 1.0 0.5 6.2 0.2 
College Prep 61.9 24.2 12.3 1.1 0.6 
Both 66.0 21.6 11.3 1.0 0.0 Degree 
track Technical/ 
Career 42.5 37.5 15.0 5.0 0.0 
12.0 0.2 
Mean Age 16.6 16.5 16.4 17.1 16.6 1.6* 0.7 
*F statistic 
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Table 9. Differences in demographic characteristics between students and their belief that 
teenagers are at risk to catch meningococcal disease. 
Most students understood that their risk for meningococcal disease decreases if they 
received the vaccine.  This was shown in two sets of questions in this study: “with and 
without the meningococcal vaccine, I am still at risk to catch meningococcal disease” [valid 
answers strongly agree to strongly disagree] and “with and without the meningococcal 
vaccine, my risk to catch meningococcal disease is…”[valid answers very high to very low].  
For each set of questions the median response was one to two units, respectively, in the lower 
risk direction for persons who have been vaccinated (p-value <0.001, for both).  See Table 
10.   
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Strongly Disagree χ2 % Disagree p-value% 
All 40.1 42.0 15.2 2.1 0.5   
Male 31.7 43.9 20.3 3.5 0.7 Sex Female 46.8 40.6 11.2 1.1 0.4 47.7 <0.001
Full pay 41.6 41.9 14.1 2.0 0.5 
Reduced 28.7 50.8 18.9 1.6 0.0 Lunch Payment Free 40.4 39.6 16.6 2.6 0.8 
11.4 0.2 
Hispanic 31.8 47.0 21.2 0.0 0.0 Ethnicity 5.1 0.3 Non-Hispanic 40.5 41.8 14.9 2.3 0.5 
White 41.7 42.8 13.4 1.8 0.4 Race Other 38.2 41.1 17.4 2.6 0.7 6.3 0.2 
College Prep 39.9 42.6 14.9 2.1 0.5 
Both 47.4 37.1 14.4 1.0 0.0 Degree 
track 11.4 0.2 Technical/ 30.0 37.5 25.0 5.0 2.5 Career 
Mean Age 16.7 16.5 16.4 16.6 16.2 2.5* 0.03 
*F statistic 
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Table 10. Perceived efficacy of vaccination.  Wilcoxon Signed Ranks Test. 
Knowledge of Recommendations  
In Georgia, all colleges require that students living in campus housing receive the 
meningococcal vaccine or at least receive information about meningococcal disease.  In 
general, most students strongly agreed or agreed that the meningococcal vaccine was 
recommended (68.9%); fewer agreed that it was required (55.4%).  Females strongly agreed 
or agreed more than males on the presence of a recommendation or requirement (72.8% 
versus 64.0%, p-value <0.001 and 59.4% versus 50.1%, p-value 0.004, respectively).  A 
decreasing trend in recommendation agreement was evident with decreasing income (as 
represented by lunch payment amount).  Those who agreed about a recommendation were 
more frequently White (p-value 0.01).  Students in the college preparatory degree track had 
greater agreement of the presence of recommendations or requirements than technical/career 
degree seekers (40.2% versus 30.0%), but this was not significant.  See Tables 11 and 12. 
 Question Median Mean p-value 
Without the meningococcal vaccine, I am at 
risk to catch meningococcal disease 2-Agree 1.98 Pair 1* <0.001 If I get the meningococcal vaccine, I am at 
risk to catch meningococcal disease 3-Uncertain 2.91 
Without the meningococcal vaccine, my risk 
to catch meningococcal disease is:  2-High 2.37 Pair 2# If I get the meningococcal vaccine, my risk to 
catch meningococcal disease is: 4-Low 3.65 
<0.001 
*Valid responses for pair 1: Strongly Agree, Agree, Uncertain, Disagree, Strongly Disagree. 
# Valid responses for pair 2: Very High, High, Uncertain, Low, Very Low. 
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Table 11. Differences in demographic characteristics between students and their knowledge 
that the meningococcal vaccine is required for students who plan to go to college. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 33.3 22.1 31.9 9.0 3.7   
Male 28.0 22.1 35.1 10.4 4.4 Sex Female 37.4 22.0 29.4 8.0 3.2 15.6 0.004 
Full pay 35.5 22.1 30.9 8.4 3.2 
Reduced 23.8 30.3 34.4 8.2 3.3 Lunch Payment Free 31.4 19.3 33.5 10.8 5.0 
15.2 0.06 
Hispanic 34.8 19.7 30.3 13.6 1.5 Ethnicity Non-Hispanic 33.2 22.2 32.0 8.8 3.8 2.8 0.6 
White 34.1 22.2 30.2 9.3 4.2 Race Other 32.2 22.0 34.0 8.8 3.1 3.1 0.5 
College Prep 32.6 21.6 32.9 9.1 3.7 
Both 43.3 27.8 18.6 8.2 2.1 Degree 
track Technical/ 
Career 30.0 22.5 32.5 7.5 7.5 
13.1 0.1 
Mean Age 16.7 16.6 16.5 16.4 6.3 3.4* 0.008 
*F statistic
 
Table 12. Differences in demographic characteristics between students and their knowledge that 
the meningococcal vaccine is recommended for students who plan to go to college. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 40.2 28.7 21.1 5.8 4.3   
Male 34.6 29.4 25.5 6.9 3.7 Sex Female 44.6 28.2 17.5 4.9 4.8 21.7 <0.001
Full pay 43.0 29.9 18.1 4.9 4.0 
Reduced 38.5 30.3 23.0 5.7 2.5 Lunch Payment Free 34.4 25.4 27.0 7.7 5.6 
22.7 0.004 
Hispanic 36.4 40.9 18.2 1.5 3.0 Ethnicity Non-Hispanic 40.4 28.1 21.2 6.0 4.4 6.6 0.2 
White 42.3 29.7 18.0 5.0 5.0 Race Other 37.6 27.5 24.8 6.7 3.4 13.2 0.01 
College Prep 40.2 28.6 21.6 5.6 4.0 
Both 45.9 28.6 11.2 6.1 8.2 Degree 
track Technical/ 
Career 30.0 30.0 30.0 5.0 5.0 
11.8 0.2 
Mean Age 16.7 16.5 16.4 16.3 16.7 5.4* <0.001
*F statistic 
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Effect of the Healthcare Practitioner, Parent, and Individual’s Beliefs  
It is assumed that a doctor’s advice has an impact on patients.  More females than 
males felt that their doctor thinks they should be vaccinated (p-value 0.004).  With race and 
degree track, differences in the dispersion of values were significant, but the values did not 
follow a discernable trend.  See Table 13.  
Table 13.  Differences in demographic characteristics between students and their belief that 
their doctor thinks that they should be vaccinated. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 22.3 22.8 47.6 4.6 2.8   
Male 18.5 21.0 51.9 5.1 3.6 Sex Female 25.4 24.2 44.2 4.1 2.1 15.6 0.004 
Full pay 23.9 23.6 45.9 4.3 2.4 
Reduced 16.1 23.7 52.5 5.1 2.5 Lunch Payment Free 20.7 20.7 49.7 5.1 3.7 
8.0 0.4 
Hispanic 21.2 28.8 45.5 3.0 1.5 Ethnicity Non-Hispanic 22.4 22.5 47.7 4.6 2.8 1.9 0.7 
White 25.6 23.8 44.3 3.4 2.9 Race Other 18.3 21.5 51.6 6.0 2.6 17.1 0.002 
College Prep 21.5 22.5 48.8 4.5 2.7 
Both 35.1 27.8 30.9 2.1 4.1 Degree 
track Technical/ 
Career 15.4 17.9 51.3 12.8 2.6 
23.8 0.002 
Mean Age 16.8 16.5 16.5 16.7 16.9 4.9* 0.001 
*F statistic 
 
Also, the belief that their doctor thinks they should be vaccinated was correlated 
significantly with agreement that the individual student should be vaccinated (0.34, p-value 
<0.001).  The belief of the doctors also significantly correlated with the belief that their 
parents think the students should be vaccinated (0.39, p-value <0.001).  See Table 14 for full 
results. 
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Table 14.  Correlation of the student’s belief that their doctor thinks that they should be 
vaccinated and other individual beliefs.  Pearson correlation coefficient was used  
Question* Pearson correlation coefficient  
P-
value 
Regardless of what others say, I think I should be vaccinated 0.34 <0.001 
My parents / guardians want me to receive all recommended 
vaccines 0.39 <0.001 
My parents / guardians think vaccines are dangerous -0.20 <0.001 
*Valid responses: Strongly Agree, Agree, Uncertain, Disagree, Strongly Disagree. 
 
The majority of students (60.2%) strongly agreed or agreed that they should be 
vaccinated, regardless of what others say.  Conversely, 11.6% disagreed or strongly 
disagreed that they should be vaccinated.  See Table 15.  Similarly, 61.3% of students 
strongly agreed or agreed that their parents think the students should be vaccinated.  10.1% 
of students disagreed or strongly disagreed that they think their parents want them 
vaccinated.  See Table 16. 
Table 15.  Differences in demographic characteristics between students and their belief that 
they should be vaccinated, regardless of what others say. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 26.5 33.7 28.2 8.3 3.3   
Male 21.6 34.5 31.3 8.8 3.7 Sex Female 30.4 33.0 25.7 7.9 2.9 14.5 0.006 
Full pay 27.3 34.2 26.5 8.4 3.4 
Reduced 21.2 38.1 29.7 7.6 3.4 Lunch Payment Free 26.4 30.9 31.5 8.3 2.9 
5.8 0.7 
Hispanic 18.2 56.1 18.2 7.6 0.0 Ethnicity Non-Hispanic 27.0 32.5 28.7 8.4 3.5 17.0 0.002 
White 27.4 34.1 26.0 8.6 4.0 Race Other 25.5 33.2 30.8 8.0 2.5 5.6 0.2 
College Prep 25.4 34.3 28.3 8.5 3.4 
Both 41.2 27.8 23.7 5.2 2.1 Degree 
track Technical/ 
Career 25.6 28.2 33.3 10.3 2.6 
13.0 0.1 
Mean Age 16.7 16.6 16.5 16.5 16.3 2.0* 0.9 
*F statistic 
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Table 16.  Differences in demographic characteristics between students and their belief that 
their parents think that they should be vaccinated. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 34.0 27.3 28.6 7.6 2.5   
Male 28.9 26.9 32.8 8.1 3.4 Sex Female 37.9 27.7 25.3 7.2 1.9 17.9 0.001 
Full pay 35.2 28.5 26.6 7.6 2.1 
Reduced 30.6 27.3 31.4 7.4 3.3 Lunch Payment Free 32.2 24.7 32.2 7.7 3.2 
7.1 0.5 
Hispanic 40.9 31.8 25.8 1.5 0.0 Ethnicity Non-Hispanic 33.6 27.1 28.7 7.9 2.7 6.8 0.1 
White 34.8 29.8 25.8 7.5 2.2 Race Other 32.9 24.4 32.0 7.7 3.0 9.1 0.06 
College Prep 32.7 27.3 29.7 7.9 2.3 
Both 52.6 27.8 10.3 4.1 5.2 Degree 
track Technical/ 
Career 27.5 22.5 40.0 7.5 2.5 
29.5 <0.001
Mean Age 16.7 16.5 16.4 16.3 16.9 5.2* <0.001
*F statistic 
 
Who Makes Vaccine Decisions? 
While parents need to give permission for adolescents under age 18 to receive 
vaccines, in general, adolescents have an opinion on the matter.  In the survey population, 
almost 40% of students agreed or strongly agreed that their parents let them decide if they 
should be vaccinated.  As Figure 2 shows, agreement increased with age, until age 19.  The 
mean age of students who agreed that they have decision making authority was greater than 
for those that do not (F statistic p-value <0.001).  Over half of students on the 
technical/career degree track agreed that they had vaccination decision making authority.  
Fewer college prep track students agreed (p-value 0.03).  See Table 17. 
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Figure 2.  A graph of percent of students that feel they have vaccine decision making 
authority, by age. 
 
 
Table 17.  Differences in demographic characteristics between students and their belief that 
they have the authority to decide if they are to be vaccinated. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 12.7 25.0 28.7 21.1 12.5   
Male 12.5 24.7 34.0 19.6 9.1 Sex Female 12.8 25.2 24.5 22.3 15.2 21.2 <0.001
Full pay 11.5 25.1 28.9 21.3 13.2 
Reduced 12.7 26.3 21.2 27.1 12.7 Lunch Payment Free 15.4 24.2 30.6 18.9 10.9 
10.3 0.2 
Hispanic 9.1 34.8 24.2 18.2 13.6 Ethnicity Non-Hispanic 12.9 24.5 28.9 21.3 12.5 4.2 0.4 
White 12.6 26.1 28.0 20.9 12.4 Race Other 12.7 23.6 29.6 21.3 12.7 1.2 0.9 
College Prep 11.9 24.8 29.2 21.4 12.8 
Both 16.3 27.6 19.4 23.5 13.3 Degree 
track Technical/ 
Career 28.2 23.1 33.3 10.3 5.1 
16.9 0.03 
Mean Age 16.8 16.7 16.5 16.4 16.4 5.2* <0.001
*F statistic 
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Vaccine Related Injury 
Perceptions of fear of vaccine induced injury were estimated by the questions: “I 
worry about mild vaccine side effects (sore arm, fever, muscle aches) from the 
meningococcal vaccine,” and “I worry about a very serious side effect from the 
meningococcal vaccine.” The median selection for each was 3-Uncertain, and about 40% of 
all surveyed students agreed that they worry about any vaccine-related injury.  More females 
than males worried about mild and serious side effects (p-value <0.001 and 0.02).  Minority 
and Hispanic students had more overall agreement that they were worried about mild and 
serious side effects more than White and non-Hispanic students (p-value <0.001 and 0.002, 
for both). Technical/career track students worried more about mild and serious side effects 
than college prep students (p-value 0.02 and 0.04).  Students who paid full price for lunch 
had less overall agreement that they were worried than students with reduced or free lunch 
(p-value 0.001 for mild and 0.002 for serious).  Students who were more worried about mild 
side effects had a tendency to be slightly younger (p-value 0.03).  See Tables 18 and 19 for 
full results.  
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Table 18.  Differences in demographic characteristics between students and their belief that 
they worry about a mild vaccine side effect. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 13.6 26.1 23.4 26.1 10.8   
Male 10.8 19.5 28.7 27.4 13.6 Sex Female 15.9 31.2 19.2 25.1 8.6 45.4 <0.001
Full pay 12.1 23.9 22.6 29.2 12.2 
Reduced 10.7 32.8 24.6 22.1 9.8 Lunch Payment Free 17.9 28.8 24.8 20.6 7.9 
25.6 0.001 
Hispanic 7.6 39.4 34.8 12.1 6.1 Ethnicity Non-Hispanic 13.9 25.4 22.8 26.8 11.1 17.2 0.002 
White 9.9 20.1 21.2 34.6 14.1 Race Other 18.0 33.2 26.0 15.9 6.8 102.9 <0.001
College Prep 13.6 25.6 23.7 26.7 10.3 
Both 11.3 25.8 17.5 25.8 19.6 Degree 
track Technical/ 
Career 22.5 37.5 22.5 12.5 5.0 
17.6 0.02 
Mean Age 16.4 16.5 16.5 16.6 16.8 2.8* 0.03 
*F statistic 
 
Table 19.  Differences in demographic characteristics between students and their belief that 
they worry about a very serious vaccine side effect. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 19.3 23.0 25.3 23.1 9.3   
Male 16.7 21.2 29.1 22.9 10.1 Sex Female 21.5 24.4 22.3 23.2 8.7 12.3 0.02 
Full pay 17.3 20.6 25.7 25.9 10.6 
Reduced 21.3 24.6 27.9 18.9 7.4 Lunch Payment Free 23.4 27.9 23.4 18.1 7.2 
24.2 0.002 
Hispanic 27.3 36.4 24.2 9.1 3.0 Ethnicity Non-Hispanic 18.9 22.3 25.3 23.8 9.7 16.5 0.002 
White 13.6 21.0 23.8 28.8 12.8 Race Other 26.2 25.4 27.0 16.1 5.2 75.8 <0.001
College Prep 19.6 22.7 26.0 22.7 9.0 
Both 15.5 20.6 16.5 32.0 15.5 Degree 
track Technical/ 
Career 22.5 35.0 22.5 15.0 5.0 
16.4 0.04 
Mean Age 16.6 16.5 16.5 16.5 16.8 1.1* 0.3 
*F statistic 
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Mistrust of Medicine  
Students were asked if they thought their parents felt that vaccines were dangerous.  
While agreement was infrequent, minority students agreed more than White students that 
their parents think vaccines are dangerous (p-value <0.001).  The less students paid for lunch, 
the more the students felt that their parents thought that vaccines were dangerous (p-value 
<0.001).  Technical/career track students believed their parents had the greatest fears towards 
vaccines when compared to college prep students (p-value 0.007).  See Table 20 for more 
results. 
 
Table 20.  Differences in demographic characteristics between students and their belief that 
their parents think vaccines are dangerous. 
Characteristic 
Strongly
Agree 
% 
Agree 
% 
Uncertain
% 
Disagree
% 
Strongly 
Disagree 
% 
χ2 p-value
All 4.6 6.9 28.9 32.9 26.6   
Male 5.6 7.4 34.3 28.1 24.5 Sex Female 3.9 6.5 24.7 36.7 28.3 22.3 <0.001
Full pay 3.1 5.4 26.7 33.8 31.0 
Reduced 5.9 5.0 37.8 30.3 21.0 Lunch Payment Free 7.7 10.9 31.1 31.6 18.6 
46.9 <0.001
Hispanic 1.5 10.6 22.7 30.3 34.8 Ethnicity Non-Hispanic 4.8 6.7 29.3 33.0 26.2 5.6 0.2 
White 3.1 5.4 25.2 35.2 31.0 Race Other 6.4 8.7 33.5 30.0 21.3 35.6 <0.001
College Prep 4.3 6.8 29.8 32.9 26.3 
Both 5.2 7.2 16.5 32.0 39.2 Degree 
track Technical/ 
Career 10.0 7.5 37.5 37.5 7.5 
20.9 0.007 
Mean Age 16.7 16.6 16.5 16.6 16.6 0.9* 0.4 
*F statistic 
 
Benefit of Education via Assembly and Movie 
Many of the students received education delivered by a member of DHR and a video 
presentation.  Many of the beliefs that were estimated by the survey could have been 
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modified by the educational experience because the presentation and the survey covered 
much of the same content.  In fact, viewing the presentation was associated with differences 
in beliefs with these students.  If students saw the presentation, they more often agreed that 
meningococcal disease was a serious illness and that teens and young adults are at risk to 
catch disease (p-value <0.001, for both).  Both of these topics were covered extensively in 
the presentation.  Also, students who saw the presentation agreed that there were at least 
recommendations for meningococcal vaccination before entry into college housing (p-value 
<0.001, for both).  Students who saw the presentation also agreed more on average that they 
thought the meningococcal vaccine is effective and that they should be vaccinated, regardless 
of what others think.  Lastly, although herd immunity was not emphasized in the 
presentation, students who saw the presentation agreed more than those who did not that 
getting a vaccination helps others as well, although results were not significant (p-value 0.6).  
See Table 21 for complete analysis.  Median results revealed that students who saw the 
presentation were more likely to feel that their risk was higher and that the meningococcal 
vaccine more effective than those who did not see the presentation (p-values 0.002 and 
0.001).  See Table 22. 
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Table 21. The effect of an educational presentation and video on student vaccination beliefs.  
Chi-square tests were performed.  Students who were unsure if they saw the presentation 
were excluded. 
Survey question Response* % Saw the presentation 
% Missed the 
presentation χ
2 p-value
SA 72.0 42.6 
A 21.6 33.6 
U 5.4 21.7 
D 0.9 1.2 
Meningococcal disease is a 
serious illness 
SD 0.1 0.8 
99.2 <0.001
SA 47.0 26.1 
A 44.5 42.9 
U 7.0 28.2 
D 1.2 2.4 
Teenagers and young adults 
are at risk to catch 
meningococcal disease 
SD 0.2 0.4 
97.9 
 
 
<0.001 
 
SA 31.4 18.4 
A 36.5 34.7 
U 21.6 33.1 
D 8.2 7.9 
Regardless of what others say, 
I think I should be vaccinated 
SD 2.4 5.9 
29.0 <0.001
SA 48.1 25.0 
A 29.9 27.9 
U 12.2 36.5 
D 5.5 6.6 
The meningococcal vaccine is 
recommended for students 
who plan to go to college 
SD 4.2 4.1 
89.9 <0.001
SA 39.7 18.4 
A 22.6 25.8 
U 25.4 40.2 
D 9.3 9.8 
The meningococcal vaccine is 
required for students who plan 
to go to college 
SD 2.9 5.7 
44.7 <0.001
SA 45.7 23.8 
A 35.7 38.5 
U 13.4 26.2 
D 4.0 9.0 
Without the meningococcal 
vaccine, I am at risk to catch 
meningococcal disease 
SD 1.2 2.5 
54.6 <0.001
SA 22.8 17.9 
A 31.3 33.3 
U 28.9 30.0 
D 9.6 11.3 
When I am vaccinated, it 
protects people around me 
SD 7.3 7.5 
2.9 0.6 
* Valid responses: Strongly Agree, Agree, Uncertain, Disagree, Strongly Disagree. 
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Table 22.  The effect of an educational presentation and video on vaccine-related beliefs. 
Mann-Whitney U test was used to determine differences in beliefs between students who did 
and did not see the presentation. 
Saw the presentation  Missed the presentation p-value Question Median 
response Mean 
Median 
response Mean  
Without the meningococcal 
vaccine, my risk to catch 
meningococcal disease is:* 
2-High 2.28 3-Uncertain 2.49 0.002 
How effective is the 
meningococcal vaccine in 
preventing disease?# 
2-Agree 2.20 3-Uncertain 2.40 0.001 
*Valid responses: Very High, High, Uncertain, Low, Very Low  
# Valid responses: Strongly Agree, Agree, Uncertain, Disagree, Strongly Disagree. 
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Chapter V-Discussion and Conclusion 
Responses from this survey described a population that had diverse perceptions 
toward vaccination.  Many students’ responses described a profile of a likely vaccinee, while 
other student’s responses indicated they were not likely to be vaccinated without changes to 
the current vaccine delivery system. 
Healthcare Contact 
In order for a person to be vaccinated, there must be contact with a healthcare 
professional; therefore, healthcare contact is vital to adolescent health.  Results of this study 
indicated most students have visited a healthcare provider within the last year.  It is important 
to note that the healthcare seeking behavior of four out of five of these adolescents already 
met the proposed recommendations that adolescents visit a healthcare source every two 
years, a result supported by other population based studies [25].  Though healthcare contact 
is a vital component of assuring vaccination in youth, merely having a healthcare visit does 
not necessarily guarantee that vaccination will occur.  It was important to reveal the 
characteristics of students who have not had a recent healthcare visit in order to focus efforts 
to improve vaccination rates for these students.  The characteristics of these students follow. 
As expected based on previous research, there were differences among socio-
demographic groups with regard to healthcare visits within the past two years.  When 
analyzing study outcomes, it was apparent that males and poorer students were less likely to 
visit a healthcare source than other adolescents.  As described previously, healthcare contact 
can be a cue to action where education of perceived susceptibility and severity can be 
addressed.  If these adolescents do not visit a healthcare provider, then a possible solution is 
to have the healthcare provider come to the adolescent.  In previous research, school-based 
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hepatitis B programs were, in addition to being an opportunity for vaccination, cost effective 
[63, 64].  Additional educational contacts could occur through school either through sports 
team related physicals or through presentations in health classes.  These opportunities could 
be utilized to inform the student about health or vaccine recommendations and disease 
related risks.   
The study population indicated that there was a gender difference between males and 
females with regard to visiting a healthcare provider within the past two years (84.3% for 
females and 75.5% for males).  Based on previous research, it was expected that the 
differences in healthcare visitation by gender were attributable to increases in female visits to 
the obstetrician/gynecologist [25].  Most current and future adolescent vaccines are targeted 
to women; therefore a logical choice to expand vaccine delivery methods is in the 
obstetrics/gynecology practice.  If every woman in this study who visited a healthcare facility 
received a recommended vaccine, then within two years an 84% coverage rate would be 
achieved.   
Doctor and Parent Beliefs  
 Vaccination recommendations must be shared by healthcare providers when an 
adolescent makes contact.  This study showed that a healthcare professional advising 
vaccination was correlated with individual adolescent and parental acceptance of vaccination 
(Table 14).  The importance of a doctor’s recommendation was revealed by student responses 
that showed those who think their doctor wanted them vaccinated had a healthcare visit 
recently and thus a potential opportunity to be vaccinated.  This study showed that both the 
healthcare visit and the healthcare provider’s recommendation decreased the level of the 
adolescent’ perceived barriers and increased perceived benefits of vaccination.  In this study 
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population, more females than males agreed that their doctor thinks they should be 
vaccinated.  This may be due to more healthcare contact in women and more opportunities 
for the doctor to share vaccination beliefs.   
 Though direct discussion and education between healthcare providers and 
adolescents is important, it is clear that education must extend beyond the adolescent to their 
parent as well.  The survey responses indicated that the beliefs of the parent played as large a 
part as the doctor’s when impacting vaccination in adolescents.  Therefore education of 
parents is important and could occur via dispersement of standardized written material within 
healthcare facilities.  This material had the opportunity to reduce barriers identified through 
the Health Belief Model.  To maximize the potential of this form of education, written 
material could be provided both in pediatric offices as well as in clinics serving adults.  In 
doing so, parents would have the potential to encounter such material both at their own 
healthcare visits and also during visits with their children to the pediatrician.  Though 
providing improved and standardized education during healthcare visits would facilitate 
improvements in vaccination rates, 19.6% of adolescents surveyed do not regularly see a 
healthcare provider.  Therefore, it may be helpful that education be provided to parents and 
adolescents outside of the healthcare setting.   Possible avenues to consider for educational 
opportunities beyond healthcare offices may include providing information during health 
classes in high school or middle school and direct-to-consumer marketing of ACIP 
recommended vaccines. 
Perceived Disease Risk 
 As a core component of the Health Belief Model, perceived severity and risk of 
disease contribute to health behavior.  That 86% of students agreed meningococcal disease 
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was serious indicated that the students believed there was a reason to avoid illness.  Almost 
as many agreed that teens were at risk to catch the disease, but did not agree as strongly.  
Even fewer students felt that, even if unvaccinated, they were at risk as individuals.  
Although the difference was slight, this was evidence that teens might recognize a problem 
but not recognize that the problem could effect them as equally.  Using the Health Belief 
Model framework, adolescents who feel invulnerable to disease have low perceived 
susceptibility.  Interventions designed to increase knowledge of risks of disease can improve 
these perceptions.  Students also agreed that their disease risk was lower if vaccinated; they 
indicated they felt that their risk was reduced from high to low after vaccination.  With these 
results, one could assume the students understand vaccinations decrease disease risk.  
Vaccination campaigns should capitalize on this belief as rationale for vaccination.  
Vaccine Related Injury 
The opposing risk of vaccine related injury could be a barrier to vaccination for 
many.  Using the Health Belief Model, if a disease prevention method comes at too high a 
cost, such as risk of injury because of vaccination, the likelihood that the adolescent would 
decide to pursue the healthy behavior of vaccination would decrease.  Since a large 
proportion of students surveyed were worried about both mild and very serious vaccine side 
effects, healthcare practitioners should convey appropriate risk-related information to 
adolescents so that they can judge their personal risk more accurately.  In this study, when 
comparisons are made between income and race groups, differences in beliefs were found.  
Students who qualified for free lunch indicated that they strongly agree or agree that their 
parents believe vaccines are dangerous twice as often as students who paid full price for 
lunch (8.5% verses 18.6%, p-value <0.001).  In addition, survey responses indicated that 
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non-White students strongly agreed or agreed that their parents think vaccines are dangerous 
more often than did white students (8.5% verses 15.1%, p-value <0.001).  These differences 
in groups may have important implications when designing vaccine interventions.  
As with disease perceived risk, females felt more worry about side effects than males.  
Special emphasis on appropriate risk related information needs to be delivered to females, 
minority groups, and poorer students who expressed greater anxiety regarding possible side 
effects than did their counterparts. 
Vaccination Decision Making 
One component of adolescent vaccine research that had not yet been confirmed is the 
effect that adolescent attitudes have on actual vaccine delivery and if the adolescent really is 
the one to make that decision.  Over 37% of students in this study perceived that they had the 
authority to make the decision of whether or not to be vaccinated.  This survey reported 
perceptions, which are often not equal to truths, so it was uncertain if perceived authority was 
actual authority.  However, Douglas County school administration officials shared that the 
students in the school district had varying levels of parent involvement.  The study revealed 
that, other than the 28.7% of students who were uncertain about their decision making 
authority, students had an opinion on whether or not to be vaccinated.  The ability to make 
vaccine decisions is an important component in the Health Belief Model with regards to 
barriers and self-efficacy.  Anecdotally, during the MCV study, students showed that despite 
having parental approval to receive MCV4, the student made the final decision when the time 
came to be vaccinated as part of the study. 
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Education 
 This study showed that students who received education from a doctor through the 
MCV study were more likely to understand disease risks, severity, and vaccine effectiveness, 
which may lead to greater vaccination rates.  These components fit into the Health Belief 
Model as perceived susceptibility, severity, benefits, and self-efficacy and are theorized to 
lead to an increase in the preventive health behavior of vaccination.  Healthcare visits for 
some students were infrequent; therefore it is critical that physicians are armed with a plan to 
provide education and vaccination counseling to an adolescent anytime there is a contact. 
Knowledge of Entry Laws 
 The aforementioned solutions may not result in vaccination for every adolescent.  For 
these adolescents, the answer is a vaccination mandate before school entry.  In this 
population, knowledge of school entry laws was associated with individual adolescent 
acceptance of vaccination.  Groups that had less agreement for knowledge of entry laws 
included males, minority, and poorer students.  This could be a result of less healthcare 
contact and fewer opportunities for information sharing.  Surprisingly, knowledge of college 
entry laws was not significantly different between college bound students and 
technical/career track students.  In the case of meningococcal disease, the vaccination (or at 
least education stating that the meningococcal vaccination should be received) is necessary to 
enter college, so it seems that knowing about the recommendation is a less important 
educational endpoint.  However, early knowledge of this requirement would enable VFC 
participants to receive vaccine for free or reduced cost before they age out of the program. 
 According to research results, some students did not agree that either they were at risk 
for disease or needed vaccination.  For these students and those who have negative feelings 
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about vaccines (11.5% of students had some level of agreement that their parents thought 
vaccines were dangerous), school entry law could be the only reason vaccination occurs.  In 
fact, school entry laws make being able to attend school perceived benefit of vaccination.  It 
is the policy of the Board of Regents of the University System of Georgia that schools have 
the option to make any vaccine recommended by ACIP required for school [33].  
Limitations 
The limitations of this study were similar to survey research in general.  While all 
students from the Douglas County school district that were included in the analysis had an 
equal opportunity to complete the survey, less than a third of students actually completed it.  
This should be considered a convenience sample and was subject to selection bias.  
Characteristics of a student that was likely to fill out a survey may be different than those 
who did not.   Because of this, it was uncertain if the survey respondents represented all 
Douglas County students.  The survey was given a few weeks before the end of the school 
year.  If a student was going to drop out, he or she would have done so earlier in the year 
before the survey was administered.  This survey could not have included drop out students. 
Additionally, the end of year overall student population was statistically different at the 0.05 
level than the survey population based on the school administrative variables, sex, 
race/ethnicity, degree track, and lunch payment status (data not shown).  This survey was self 
reported and was subject to biases in responses.  However, even though the survey responses 
may only approximate the truth, one important goal of this research was to identify what 
students think and how these perceptions might affect behavior.   
Douglas County administrative records combined race and ethnicity into one 
category.  This research divided this information into separate race and ethnicity variables.  
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Therefore students could only have been classified by race or ethnicity, not both.  This could 
have lead to misclassification bias as people conventionally can be both a member of a race 
and an ethnicity.  Many of these students watched a presentation and video about 
meningococcal disease and vaccination when they were being recruited for the MCV study.  
This education and potential participation in the MCV study reduced generalizability of this 
study outside of this population.  While stratifying by presentation (Tables 21 and 22) 
showed the importance and effect of the study’s education, the education and recruitment 
efforts (posters, announcements) was likely to render students in the Douglas County school 
system different than the average student.  The comparisons in this study were associations, 
thus causality cannot be assumed. 
Health Belief Model 
 In this study, survey questions correspond to Health Belief Model components.  In 
addition to students understanding their susceptibility, they also understood that 
meningococcal disease was serious.  This study identified student groups where this was not 
so, for whom risk information needs to be specialized.  Most importantly, most students were 
aware that the benefit from receiving the meningococcal vaccine was reduction in disease 
risk.  Vaccine efficacy information must be shared with others.  Mistrust of medicine and 
fear of vaccination side effects can be classified as a barrier to vaccination.  Those with 
mistrust need reassurances from a trusted resource to replace misinformation.  If providers 
advocate vaccination at every contact, recent healthcare can be considered a cue to action.  
Self efficacy could only be mildly approximated through the question: “How effective is the 
meningococcal vaccine,” that by receiving the vaccine the student identified with a range of 
effectiveness.  See Table 23 for Health Belief Model constructs. 
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Recommendations 
Table 23. Health Belief Model component and vaccination counterpart 
Health Belief Model 
Healthcare 
It is critical that adolescents have a healthcare contact.  The responses of this survey 
population showed that for four out of five students (80.4%), had a healthcare visit within the 
last two years, as recommended by AAP and SAM.  However, in order to encourage the 
other 20% of students to make contact with a healthcare professional during these vital 
adolescent years, improvements must occur in the publicizing of the need for an adolescent 
healthcare visit.  Healthcare providers serving pre-adolescents are in a perfect position to 
inform parents of the need for a future adolescent visit.   
In this survey population, 55.1% strongly agreed or agreed that their doctor thinks 
they should be vaccinated.  This percentage seems low when compared to the 80.4% of 
children who reported a healthcare visit within the past two years.  When this information is 
considered along with the survey data that indicate that 37.7% of students strongly agreed or 
agreed that they have vaccine decision making authority, it becomes clear that in order to 
solidify the adolescent’s perception that vaccines are beneficial, practitioners must 
recommend vaccination to every adolescent at every healthcare visit as a solution to reduce 
disease risk.   
component Vaccination counterpart 
Perceived susceptibility Knowledge that I am at risk for meningococcal disease 
Perceived severity Knowledge that meningococcal disease is a serious illness 
Perceived benefits Knowing that vaccination reduces my risk of disease 
Perceived barriers Fear of vaccine side effects 
Cues to action Recent healthcare visit 
Self-efficacy Knowledge that the vaccine is effective 
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In the survey population, 11.6% of adolescents showed some level of disagreement 
that they think they should be vaccinated while 10.1% of adolescents showed some level of 
disagreement that their parents think they should be vaccinated.  Healthcare practitioners 
may not be able to recognize the one student in 10 whose individual or parental beliefs are 
not conducive to vaccination.  Because of this, healthcare providers serving adolescents must 
discuss the topic of vaccination with every adolescent.  In cases where the client has vaccine 
misconceptions, communication is necessary.  According to the survey population, non-
White and poorer students, when compared to others, had higher vaccine related worries 
about mild and serious vaccine side effects and believed that vaccines were more dangerous.  
Practitioners that serve these population groups should be prepared to discuss vaccine related 
side effects and misconceptions to correct perceptions that pose a barrier to vaccination.   
 
School 
This study has identified a number of adolescents who, according to the Health Belief 
Model, present with barriers to vaccination.  In the survey population, 19.6% had not visited 
a healthcare provider within the last two years, 11.6% did not believe that they should be 
vaccinated, 39.7% strongly agreed or agreed that they were concerned about mild vaccine 
side effects, and 42.3% strongly agreed or agreed that they were concerned about a serious 
vaccine side effect.  According to the Health Belief Model, the students described above lack 
the perceptions and beliefs that contribute to the decision to be vaccinated.  For these 
students, a non-behavioral intervention, such as school entry laws, may be a solution.  To 
protect students who are unlikely to be vaccinated for behavioral reasons, school entry laws 
should continue.  Another way to strengthen school entry laws regarding vaccines is to 
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institute policies that require students be up-to-date with vaccination before they are allowed 
to compete in sports.  Though strengthening school entry laws will likely improve 
vaccination for students with access to healthcare providers, meeting these entry 
requirements is difficult for students who have limited or no access to healthcare 
practitioners.  Hence, in areas without access to healthcare, school based clinics could be 
instituted.  Additionally, in this study, the school-based education had a large effect on the 
knowledge and beliefs of adolescents, therefore schools should be used to deliver vaccination 
related messages to students. 
Increasing Adolescent Demand for Vaccine 
According to data from this survey, 37.7% of adolescents agreed that their parents or 
guardians allowed the student themselves to make the decision regarding whether or not to be 
vaccinated.  Because of this, the perceptions of adolescents regarding vaccines should be 
considered when designing pro-vaccine interventions.  In order to strengthen the 
effectiveness of such campaigns, special consideration should be given to targeting those 
adolescents and their families who do not currently believe in the importance of vaccination 
or who are fearful of vaccination.   
Results of this study found differences in perceived vaccine safety among various 
groups of students.  When comparisons were made between income and race groups, survey 
responses indicated that poorer students and students who were non-White strongly agreed or 
agreed more than other students that their parents believed vaccines were dangerous and they 
worried about a mild or serious side effect.  Clinics that serve these populations need to be 
aware of these perceptions and their impact on the individual’s decision to be vaccinated.  In 
order to overcome these perceptions, healthcare providers need to be prepared to effectively 
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communicate vaccination safety issues with materials designed for poor and non-White 
populations. 
In summary, based on the information from this study, public health practitioners 
should:  
1. Healthcare practitioners should inform parents of the need for adolescent visits. 
2. Recommend vaccination for adolescents to every adolescent and their parents 
3. Discuss vaccination for adolescents with every adolescent and their parents at every 
healthcare visit to improve perceived prevention benefits of vaccination. 
4. Be prepared to discuss possible vaccine side effects and misconceptions effectively 
with non-White and poor populations. 
5. Consider schools as an environment to deliver vaccination related messages to 
students. 
6. Consider the perceptions of adolescents, in addition to their parents, when designing 
pro-vaccine interventions. 
7. Specifically target adolescents and their families who do not currently believe in the 
importance of vaccination or who are fearful of vaccination. 
Future Studies 
This study uses the context of the Health Belief Model to describe vaccine related 
knowledge, attitudes, and beliefs of adolescents.  Using this framework, this study identified 
behavioral endpoints to estimate the likelihood of adolescent vaccination.  Associating the 
behavioral endpoints with actual vaccination records and rates of disease could increase our 
understanding between knowledge, attitudes, and beliefs toward vaccination and actual 
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vaccination and reduction of disease.  A study integrating these components could identify 
behavioral constructs to focus on. 
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